Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation
  2. Gao, Ji-Liang; Weaver, Joseph D.; Tuo, Jingsheng; Wang, Long Q.; Siwicki, Marie; Despres, Daryl; Lizak, Martin; Schneider, Erich H.; Kovacs, William; Maminishkis, Arvydas; Chen,Keqiang; Yoshimura, Teizo; Wang,Jiming; Chan, Chi Chao; Murphy, Philip M.
  3. FASEB Journal. 2021, Feb; 35(2):
  1. 2.   Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
  2. Yao, X. H.; Liu, Y.; Chen, K. Q.; Gong, W. H.; Liu, M. Y.; Bian, X. W.; Wang, J. M.
  3. International Immunopharmacology. 2011, Dec; 11(12): 1961-1966.
  1. 3.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 4.   Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate
  2. Howard, O. M. Z.; Dong, H. F.; Su, S. B.; Caspi, R. R.; Chen, X.; Plotz, P.; Oppenheim, J. J.
  3. Blood. 2005, JUN 1; 105(11): 4207-4214.
  1. 5.   Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis
  2. Le, Y. Y.; Ye, R. D.; Gong, W. H.; Li, J. X.; Iribarren, P.; Wang, J. M.
  3. Febs Journal. 2005, FEB; 272(3): 769-778.
  1. 6.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 7.   Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
  2. Partida-Sanchez, S.; Iribarren, P.; Moreno-Garcia, M. E.; Gao, X. L.; Murphy, P. M.; Oppenheimer, N.; Wang, J. M.; Lund, F. E.
  3. Journal of Immunology. 2004 172(3): 1896-1906.
  1. 8.   Humanin, a newly identified neuroprotective factor, uses the g protein-coupled formylpeptide receptor-like-1 as a functional receptor
  2. Ying, G. G.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Zhang, N.; Yu, Z. X.; Le, Y.; Cui, Y.; Wang, J. M.
  3. Journal of Immunology. 2004 172(11): 7078-7085.
  1. 9.   Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor
  2. Sun, R. H.; Iribarren, P.; Zhang, N.; Zhou, Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Chertov, O.; Bednar, F.; Rogers, T. J.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 2004 173(1): 428-436.
  1. 10.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 11.   Receptors for chemotactic formyl peptides as pharmacological targets
  2. Le, Y. Y.; Yang, Y. M.; Cui, Y. H.; Yazawa, H.; Gong, W. H.; Qiu, C. P.; Wang, J. M.
  3. International Immunopharmacology. 2002 2(1): 1-13.
  1. 12.   Pleiotropic roles of formyl peptide receptors
  2. Le, Y. Y.; Oppenheim, J. J.; Wang, J. M.
  3. Cytokine & Growth Factor Reviews. 2001 12(1): 91-105.
  1. 13.   The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor
  2. He, R.; Tan, L.; Browning, D. D.; Wang, J. M.; Ye, R. D.
  3. Journal of Immunology. 2000 165(8): 4598-4605.
  1. 14.   N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes
  2. Le, Y. Y.; Jiang, S.; Hu, J. Y.; Gong, W. H.; Su, S. B.; Dunlop, N. M.; Shen, W. P.; Li, B. Q.; Wang, J. M.
  3. Clinical Immunology. 2000 96(3): 236-242.
  1. 15.   Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation
  2. Le, Y. Y.; Gong, W. H.; Li, B. Q.; Dunlop, N. M.; Shen, W. P.; Su, S. B.; Ye, R. D.; Wang, J. M.
  3. Journal of Immunology. 1999 163(12): 6777-6784.
  1. 16.   T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors
  2. Su, S. B.; Gao, J. L.; Gong, W. H.; Dunlop, N. M.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 1999 162(10): 5924-5930.
  1. 17.   A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
  2. Su, S. B.; Gong, W. H.; Gao, J. L.; Shen, W. P.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Experimental Medicine. 1999 189(2): 395-402.
  1. 18.   A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R
  2. Deng, X. Y.; Ueda, H.; Su, S. B.; Gong, W. H.; Dunlop, N. M.; Gao, J. L.; Murphy, P. M.; Wang, J. M.
  3. Blood. 1999 94(4): 1165-1173.
  1. 19.   T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor
  2. Su, S. B.; Gong, W. H.; Gao, J. L.; Shen, W. P.; Grimm, M. C.; Deng, X. Y.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Blood. 1999 93(11): 3885-3892.
  1. 20.   Opiates Transdeactivate Chemokine Receptors - Delta and Mu Opiate Receptor-Mediated Heterologous Desensitization
  2. Grimm, M. C.; Benbaruch, A.; Taub, D. D.; Howard, O. M. Z.; Resau, J. H.; Wang, J. M.; Ali, H.; Richardson, R.; Snyderman, R.; Oppenheim, J. J.
  3. Journal of Experimental Medicine. 1998 188(2): 317-325.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel